This position serves as a regional subject matter expert responsible for the lifecycle management of tezepelumab across asthma, nasal polyps, and eosinophilic esophagitis.
Base: $136,985.60 to $179,793.60 annually; Bonus/Equity: Annual Variable Pay Bonus and Long-Term Incentive Program eligibility; Benefits: Flex Benefits, Retirement Savings, 4 weeks vacation, Personal Days
Must-have
Nice-to-have
Not specified